BlackRock’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Sell |
|
|||||
|
2025
Q1 | $3.57M | Buy |
|
|||||
|
2024
Q4 | $5.3M | Buy |
|
|||||
|
2024
Q3 | $3.14M | Sell |
|
|||||
|
2024
Q2 | $1.69M | Sell |
|
|||||
|
2024
Q1 | $8.9M | Sell |
|
|||||
|
2023
Q4 | $7.66M | Sell |
|
|||||
|
2023
Q3 | $9.48M | Sell |
|
|||||
|
2023
Q2 | $20.7M | Buy |
|
|||||
|
2023
Q1 | $27.9M | Buy |
|
|||||
|
2022
Q4 | $48.2M | Buy |
|
|||||
|
2022
Q3 | $69.9M | Buy |
|
|||||
|
2022
Q2 | $51.2M | Buy |
|
|||||
|
2022
Q1 | $67.5M | Sell |
|
|||||
|
2021
Q4 | $87.5M | Buy |
|
|||||
|
2021
Q3 | $102M | Buy |
|
|||||
|
2021
Q2 | $117M | Sell |
|
|||||
|
2021
Q1 | $123M | Buy |
|
|||||
|
2020
Q4 | $149M | Sell |
|
|||||
|
2020
Q3 | $93.5M | Sell |
|
|||||
|
2020
Q2 | $92.7M | Buy |
|
|||||
|
2020
Q1 | $59.7M | Sell |
|
|||||
|
2019
Q4 | $79.8M | Sell |
|
|||||
|
2019
Q3 | $86.8M | Buy |
|
|||||
|
2019
Q2 | $102M | Buy |
|
|||||
|
2019
Q1 | $79.5M | Sell |
|
|||||
|
2018
Q4 | $96.8M | Buy |
|
|||||
|
2018
Q3 | $141M | Buy |
|
|||||
|
2018
Q2 | $115M | Buy |
|
|||||
|
2018
Q1 | $127M | Sell |
|
|||||
|
2017
Q4 | $113M | Buy |
|
|||||
|
2017
Q3 | $101M | Buy |
|
|||||
|
2017
Q2 | $49.5M | Buy |
|
|||||
|
2017
Q1 | $29.2M | Buy |
|
|||||
|
2016
Q4 | $16K | Sell |
|
|||||
|
2016
Q3 | $29K | Sell |
|
|||||
|
2016
Q2 | $39K | Sell |
|
|||||
|
2016
Q1 | $44K | Buy |
|
|||||
|
2015
Q4 | $18K | Hold |
|
|||||
|
2015
Q3 | $11K | Hold |
|
|||||
|
2015
Q2 | $22K | Sell |
|
|||||
|
2015
Q1 | $33K | Hold |
|
|||||
|
2014
Q4 | $31K | Hold |
|
|||||
|
2014
Q3 | $22K | Hold |
|
|||||
|
2014
Q2 | $31K | Buy |
|
|||||
|
2014
Q1 | $29K | Buy |
|
|||||
|
2013
Q4 | $21K | Buy |
|
|||||
|
2013
Q3 | $14K | Hold |
|
|||||
|
2013
Q2 | $11K | Buy |
|